•  
  •  
  •  
  •  

2025-12-17 20:28:51

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Multi Commodity Exchange of India Ltd fixes Jan 2, 2026 as record date for stock split
  • ASN Bank signs a contract with HCLTech to accelerate digital transformation and enhance customer experience
  • Sharika Enterprises Ltd receives order worth Rs. 1.13 crore
  • AG Enviro Infra Projects Pvt. Ltd. has secured MSW collection and transportation contracts worth approximately ₹1,330 crore from BMC
  • Steel Exchange India Ltd's flagship products receives GreenPro Certification

Keywords Selected:  EIR

Stock Report

  • Lupin receives EIR from US FDA for its Nagpur Injectable Facility
  • Granules Life Sciences Pvt Ltd facility receives EIR from USFDA
  • Indoco receives EIR from the USFDA for its API manufacturing facility at Patalganga
  • Zydus receives EIR for the injectable facility located at Jarod
  • Lupin Receives EIR from U.S. FDA for its Aurangabad (CSN) Facility
  • Zydus receives EIR for the oncology injectable manufacturing facility in SEZ1, Ahmedabad
  • Alembic Pharmaceuticals Ltd receives EIR from USFDA for facility at Panelav
  • SMS Pharmaceuticals Ltd receives EIR from USFDA for Central Laboratory Analytical Services
  • Unichem Laboratories Ltd receives EIR from USFDA classifying Roha API facility as VAI
  • SMS Lifesciences India Ltd receives EIR with VAI status from USFDA for API facility at Kazipally
  • EIR from USFDA, for Shilpa Medicare Ltd. Unit VI, Bengaluru.
  • Neuland Laboratories Ltd receives EIR from USFDA for Unit 2 at Pashamylaram Village
  • Concord Biotech Limited receives EIR from USFDA for API facility at Dholka
  • Alembic Pharmaceuticals Ltd receives EIR from USFDA for API-III facility at Karakhadi
  • Zydus receives EIR for the API manufacturing facility at Ankleshwar
  • Zydus receives EIR for the API manufacturing facility at Dabhasa
  • Zydus receives EIR for the Ambernath API manufacturing facility
  • India Glycols Limited receives EIR from USFDA for Dehradun Plant
  • USFDA classifies Emcure Pharmaceuticals Ltd's API facility at Kurkumbh as VAI
  • Lupin receives EIR from US FDA for its Injectable Facility in Nagpur
  • Laurus Labs Limited receives EIR for API facility Unit-4
  • Jubilant Cadista Pharmaceuticals Inc., USA's facility receives EIR from USFDA
  • Lupin Receives EIR from U. S. FDA for its Somerset Manufacturing Facility
  • Aarti Drugs Ltd receives EIR from USFDA for Tarapur API facility

Latest Post

  • Multi Commodity Exchange of India Ltd fixes Jan 2, 2026 as record date for stock split
  • ASN Bank signs a contract with HCLTech to accelerate digital transformation and enhance customer experience
  • Sharika Enterprises Ltd receives order worth Rs. 1.13 crore
  • AG Enviro Infra Projects Pvt. Ltd. has secured MSW collection and transportation contracts worth approximately ₹1,330 crore from BMC
  • Steel Exchange India Ltd's flagship products receives GreenPro Certification


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024